The Effect of Melatonin Modulation of Non-coding RNAs on Central Nervous System Disorders: An Updated Review.

The Effect of Melatonin Modulation of Non-coding RNAs on Central Nervous System Disorders: An Updated Review.
Curr Neuropharmacol. 2020 May 02;:
Authors: Lu J, Luo Y, Mei S, Fang Y, Zhang J, Chen S
Abstract
Melatonin is a hormone produced in and secreted by the pineal gland. Besides its role in regulating circadian rhythms, melatonin has a wide range of protective functions in central nervous system (CNS) disorders. The mechanisms underlying this protective function are associated with the regulatory effects of melatonin on related genes and proteins. In addition to messenger ribonucleic acid (RNA) that can be translated into protein, an increasing number of non-coding RNAs in the human body are proven to participate in many diseases. This review discusses the current progress of research on the effects of melatonin modulation of non-coding RNAs (ncRNAs) including microRNA, long ncRNA, and circular RNA. The role of melatonin in regulating common pathological mechanisms through these ncRNAs are also summarized. Furthermore, the ncRNAs currently shown to be involved in melatonin signaling in CNS diseases are discussed. The information compiled in this review will open new avenues for future research into melatonin mechanisms and provide a further understanding of ncRNAs in the CNS.
PMID: 32359338 [PubMed - as supplied by publisher]

Source: Current Neuropharmacology - May 1, 2020 Category: Drugs & Pharmacology Authors: Lu J, Luo Y, Mei S, Fang Y, Zhang J, Chen S Tags: Curr Neuropharmacol Source Type: research